Eversight

“The 990 is reviewed by the ceo and cfo prior to filing. Completed 990 is provided via e-mail to all board members for comments and questions prior to filing.”

“The policy is reviewed during new employee orientation and annually with the entire staff and board of directors. Any potential conflicts of interest are reviewed by senior staff upon discovery.”

“A performance review is conducted by the board hr committee with ceo; merit increase is recommended by the hr committee and approved by the board. The ceo is not part of compensation discussion and ceo does not participate in the selection of board members. The ceo salary is compared to salaries of other ceo's at peer organizations; other eye banks, opos, other nonprofit organizations of similar size. In 2016 the organization engaged the services of an independent consultant to conduct a leadership compensation analysis. Their source of salary information is the 990's issued by peer organizations, michigan nonprofit association salary survey, published budgets, web-based research through foia sources and independent salary survey data.”

“Performance review for officers and key employees is conducted by the employees' immediate manager; merit increases are recommended by the manager and approved by the ceo. Salaries of officers and key employees are compared to salaries of other similar positions at peer organizations; other eye banks, opos, other nonprofit organizations of similar size. A report is provided to the hr committee of the board of directors for their review. In 2016 the organization engaged the services of an independent consultant to conduct a leadership compensation analysis. Their source of salary information is the 990's issued by peer organizations, michigan nonprofit association salary survey, published budgets, web-based research through foia sources and independent salary survey data.”

“Governing documents are available upon request.”

“Eversight's mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Blinding eye diseases affect 80 million americans. That means millions of people cannot see their loved ones, drive to work or read the newspaper on a sunday morning. Their vision loss results in an economic impact of 51.4 billion every year in the united states alone. Eversight envisions a world without blindness-a world where all mothers can see their children and all children can grow up to lead independent, productive lives through the gift of sight. To make vision a reality for all, eversight continuously works to expand its reach, connect more effectively with communities in need and provide the gift of sight to everyone.”

“Volunteers provide various types of services, including leadership, through our board of directors (national), and our service area advisory boards. We also work with members of the lions club in michigan and throughout our service areas to share information about eversight and eye donation, and to gather intel and facilitate meaningful connections in the local communities we serve. Volunteers help plan events such as our illinois gift of sight charity event, and our michigan-based gift of sight golf classic, and serve as representatives at donor family gatherings and other events.”

“Resoring sight in 2020, eversight provided the gift of sight to more than 6,500 people across the united states and around the world. Eversight's work began in 1947 with the establishment of the fourth eye bank in the united states, then known as the illinois eye-bank. Over time, nonprofit eye banks were established in every state to meet the critical demand for corneal tissue to treat preventable blindness. In 1985, the illinois eye-bank and michigan eye-bank formed a partnership- one that would earn a reputation for clinical excellence made possible by some of the finest medical directors, staff and board members in the eye banking field. The success of the organization attracted affiliations with other regional eye banks forming one of the largest networks of eye banks in the u.s. In 2015, the network became known as eversight, all working together as a unified operation to deliver the highest quality services to surgeons and their patients and to continue to grow our impact around the world. Eversight faced challenges in 2020 and saw them through to serve our surgeons, their patients and donor families. On march 18, 2020, u.s. Cornea transplants were immediately halted due to the pandemic. No one knew how long it would last, but with sacrifice, innovation and steadfast determination, we kept hope in sight. As the virus rapidly spread, no one knew when transplants might resume and the financial impact was immediate. Providing for cornea transplantation accounts for 94 percent of eversight's operating revenue, and like many nonprofits, we canceled fundraisers we count on to support our work. That included our annual gala, our largest annual fundraiser to help low-income patients. Meanwhile, the pandemic was eliminating jobs and health insurance coverage at historic rates across the country. Even with no revenue coming in, we developed new protocols, testing, training and readiness to meet the demand once transplants could resume. In june 2020, we went above and beyond regulatory guidance and began testing potential surgical tissue donors for sars-cov-2. The team's expertise and our rigorous standards helped ensure patient safety and the safety of donors' gifts of tissue for transplantation, once transplants could resume. In this new physically distanced world, we quickly developed and began offering virtual webinars to help surgeons stay on top of evolving technology and covid-19 science and safety. Eversight became the first eye bank to develop virtual wet lab training for surgeons to practice their surgical techniques. We provided the technology for surgeons-wherever they are in the world-to come together online and practice with individualized real-time guidance from leading surgeon instructors. More than 640 surgeons and other clinicians received training through eversight in 2020, more than doubling our impact over any prior year.”

“Finding a cure in the pursuit to eliminate blinding eye diseases, eversight established the eversight center for vision and eye banking research in cleveland, ohio, to provide leading ophthalmology researchers with the resources they need to find cures and treatments for eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Eversight provided more than 2,600 tissues for research and education purposes in 2020. Our in-house research team also provided eversight partners with valuable research and development services, and pioneered new eye banking practices, including critical clinical adaptations for tissue safety during the pandemic. Our research and clinical leadership and staff are highly involved primary and co-investigators, performing research and authoring publications that expand the boundaries of vision science, knowledge and possibility. Eversight produced the research the world needed in 2020, investigating if sars-cov-2 is present in eye tissue. Our work took place in cleveland, chicago, ann arbor and in new jersey-all heavily impacted by covid-19-with research partners at chicago cornea consultants and rush university, kellogg eye center and the university of michigan medical school, and wayne state university. By october 2020, our findings showed a small but noteworthy prevalence of sars-cov-2 in ocular tissues from individuals who died from covid-19. Our research continues for all those in need of safe sight-restoring transplants and for all those awaiting a cure for non- corneal blindness. Eversight has a longstanding track record of research and development, to date awarding more than 4 million in grants that stimulate pioneering clinical and basic science research aiming to develop new ways to restore sight, prevent blindness and ultimately help patients live life to the fullest. Since 1980, our eye & vision research grant program has supported researchers at leading academic medical institutions including harvard, tufts, cleveland clinic, case western reserve, university of michigan, northwestern and more. By design, eversight's grant program provides critical, early-stage funding that is intended to drive foundational research and discovery. Many of these projects have stimulated larger-scale studies and won further financial support from the national institutes of health. In the 2020-2021 funding cycle, eversight awarded grants to advance studies on transplant graft rejection, sars-cov-2 and the eye, fuchs dystrophy, dry eye and novel cornea therapies, led by researchers at harvard medical school, university of illinois college of medicine and wayne state university school of medicine. Each year, recipients are selected by an independent review panel of academic researchers and ophthalmologists. This distinguished panel awards proposals that align with eversight's mission to restore sight and prevent blindness through meaningful scientific inquisition.”

“Sustainable international impact eversight worked with surgeons in 27 countries in 2020 to provide the gift of sight through surgical tissue provision. Eversight is focused on meeting the humanitarian need for cornea tissues in countries where sight-restoring corneal transplant procedures would otherwise be completely unavailable. The beneficiaries of our surgical tissue provision and community eye bank development initiatives include the hundreds of thousands of people who suffer from eye injuries and blinding eye diseases that can be treated through corneal transplantation. According to the world health organization, every dollar spent on improving eye health in underdeveloped areas generates a four-fold return on investment. To address systemic unmet need, eversight actively works with medical professionals, governments, vision health organizations and other ngos in regions lacking eye banks and infrastructure, including the middle east, pakistan and south korea. With proven eye banking and technical training practices-and having played a part in the elimination of the u.s. Cornea transplant waiting list-eversight uniquely qualified to work with countries lacking transplant programs to help them establish a national network for eye banking and cornea donation with culturally appropriate donation models and state-of-the-art clinical capabilities. Eighty-nine percent of vision-impaired people live in low- and middle- income countries. In 2019, eversight worked with pakistan to open its first state-of-the-art eye banks as part of a new national eye banking network. The pandemic suspended most of our planned work for 2020 to help pakistan develop its eye banking and community donation program. Despite the challenges of the pandemic, the new al shifa eye bank in rawalpindi worked with its first ever local eye tissue donor in july 2020. We collaborated with al shifa staff on optimizing donor family and recipient communications, and supported their first-ever public outreach campaign. The work continues-and it has generated a national movement for organ, tissue and eye donor registration led by local professionals who tirelessly educate and advocate for the gift of sight. Blinding eye diseases affect hundreds of millions worldwide. Globally, an estimated 285 million people are visually impaired-many with treatable conditions, but without access to care. That means millions of people cannot see their loved ones, let alone work to provide for their families. Vision loss results in substantial economic impact worldwide due to the inability of people who are vision impaired to contribute in their communities. Eversight envisions a world without blindness-a world where all people in every community can lead independent, productive lives through the gift of sight. While providing for immediate global cornea transplant needs with u.s. Donor tissue, eversight continues to empower international communities to take meaningful, sustainable steps every day to make vision a reality for all.”

“Special events expenses 6,742 special events expenses -6,742”